Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm Preeclampsia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 • 3,707 citations
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
2000 • 3,189 citations
Circulating angiogenic factors and the risk of preeclampsia*
2004 • 2,591 citations
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 • 1,222 citations
The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
2006 • 1,099 citations
The Two Stage Model of Preeclampsia: Variations on the Theme
2008 • 801 citations
Prevention of Premature Birth
1998 • 778 citations
Subclassification of Preeclampsia
2003 • 741 citations
Hypertensive disorders in pregnancy
1985 • 668 citations
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
2008 • 660 citations
Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
1996 • 574 citations
Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean
1992 • 538 citations
Maternal-Fetal Medicine
2020 • 494 citations
Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks
2011 • 437 citations
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
2009 • 396 citations
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
2009 • 261 citations
Circulating Angiogenic Factors in Early Pregnancy and the Risk of Preeclampsia, Intrauterine Growth Restriction, Spontaneous Preterm Birth, and Stillbirth
2007 • 210 citations
Placental Growth Factor and Soluble FMS-Like Tyrosine Kinase-1 in Early-Onset and Late-Onset Preeclampsia
2007 • 182 citations
Mapping the Theories of Preeclampsia and the Role of Angiogenic Factors
2007 • 172 citations
Hypertensive disorders in pregnancy
1979 • 156 citations
Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
2005 • 133 citations
Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia
2004 • 133 citations
Pregnancy-Related Hypertension
2009 • 127 citations
Effective Prediction of Preeclampsia by a Combined Ratio of Angiogenesis-Related Factors
2008 • 116 citations
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation
2008 • 107 citations
Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11+0 to 13+6 weeks of gestation
2008 • 102 citations
Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia Are More Pronounced in Women with Early Onset Severe Preeclampsia
2007 • 82 citations
Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre‐eclampsia
2010 • 65 citations
Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia
2007 • 63 citations
Maternal-fetal medicine
1995 • 44 citations
Urinary cotinine concentration confirms the reduced risk of preeclampsia with tobacco exposure
1999 • 44 citations
Midgestation Maternal Serum 25-Hydroxyvitamin D Level and Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio as Predictors of Severe Preeclampsia
2011 • 32 citations